Biodesix
(NASDAQ) BDSX
Biodesix Financials at a Glance
Market Cap
$129.54M
Revenue (TTM)
$88.50M
Net Income (TTM)
$35.27M
EPS (TTM)
$-4.73
P/E Ratio
-2.78
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$13.25
Volume
732
Open
$13.61
Price
$13.25
Volume
732
Open
$13.61
Previous Close
$13.25
Daily Range
$13.04 - $13.61
52-Week Range
$3.44 - $20.21
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$13.25
Volume
732
Open
$13.61
Previous Close
$13.25
Daily Range
$13.04 - $13.61
52-Week Range
$3.44 - $20.21
BDSX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biodesix
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
334
CEO
Scott Hutton
Website
www.biodesix.comHeadquarters
Boulder, CO 80301, US
BDSX Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-31%
Net Income Margin
-40%
Return on Equity
-383%
Return on Capital
-40%
Return on Assets
-40%
Earnings Yield
-35.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$129.54M
Shares Outstanding
9.86M
Volume
732
Short Interest
0.00%
Avg. Volume
158.30K
Financials (TTM)
Gross Profit
$66.59M
Operating Income
$27.87M
EBITDA
$21.88M
Operating Cash Flow
$23.27M
Capital Expenditure
$259.00K
Free Cash Flow
$23.53M
Cash & ST Invst.
$18.99M
Total Debt
$72.85M
Biodesix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.75M
+40.8%
Gross Profit
$23.88M
+48.4%
Gross Margin
83.03%
N/A
Market Cap
$129.54M
N/A
Market Cap/Employee
$474.50K
N/A
Employees
273
N/A
Net Income
$3.98M
+51.8%
EBITDA
$569.00K
+88.8%
Quarterly Fundamentals
Net Cash
$53.87M
-50.8%
Accounts Receivable
$9.04M
+5.0%
Inventory
$0.00
N/A
Long Term Debt
$71.48M
+16.7%
Short Term Debt
$1.37M
+85.1%
Return on Assets
-40.31%
N/A
Return on Invested Capital
-39.80%
N/A
Free Cash Flow
$629.00K
+112.6%
Operating Cash Flow
$778.00K
+119.0%